These results are in line with the findings from Mandal et al who described that HNSCC cells with an EMT phenotype had a higher level of Src activation, and that cells treated with a Src inhibitor showed an upregulation of E-cadherin [40]. Here, CDH1 is linked to head and neck squamous cell carcinoma.